FFCP PHASE1:Hg19::chr9:112189474..112189486,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=5774 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=9655 | |||
|TSSclassifier=not | |||
|UniProt=Q68E08 | |||
|association_with_transcript=-70bp_to_CR749204_5end | |||
|coexpression_cluster_id=C99 | |||
|description=CAGE_peak_15_at_PTPN3_5end | |||
|id=chr9:112189474..112189486,- | |||
|ontology_enrichment_celltype=CL:0002127!2.78e-26!1;CL:0000914!2.78e-26!1;CL:0000911!2.78e-26!1;CL:0000814!2.78e-26!1;CL:0002042!2.78e-26!1;CL:0002039!2.78e-26!1;CL:0002040!2.78e-26!1;CL:0002041!2.78e-26!1;CL:0000084!2.20e-16!25;CL:0000827!2.20e-16!25;CL:0000893!7.30e-14!2;CL:0002489!7.30e-14!2;CL:0000809!7.30e-14!2;CL:0000808!7.30e-14!2;CL:0000894!7.30e-14!2;CL:0000806!7.30e-14!2;CL:0000807!7.30e-14!2;CL:0000805!7.30e-14!2;CL:0002425!7.30e-14!2;CL:0002619!1.54e-09!3;CL:0000838!4.22e-08!52;CL:0000542!5.90e-08!53;CL:0000051!5.90e-08!53;CL:0002032!2.56e-07!165;CL:0000837!2.56e-07!165;CL:0000037!5.14e-07!172;CL:0000566!5.14e-07!172 | |||
|ontology_enrichment_celltype_v019=CL:0002127;1.88e-50;1!CL:0000911;1.88e-50;1!CL:0000814;1.88e-50;1!CL:0000084;1.02e-18;25!CL:0000542;5.06e-07;53 | |||
|ontology_enrichment_celltype_v019_2=CL:0002127,2.42e-50,1;CL:0000914,2.42e-50,1;CL:0000911,2.42e-50,1;CL:0000814,2.42e-50,1;CL:0002042,2.42e-50,1;CL:0002039,2.42e-50,1;CL:0002040,2.42e-50,1;CL:0002041,2.42e-50,1;CL:0000893,5.56e-26,2;CL:0002489,5.56e-26,2;CL:0000809,5.56e-26,2;CL:0000808,5.56e-26,2;CL:0000894,5.56e-26,2;CL:0000806,5.56e-26,2;CL:0000807,5.56e-26,2;CL:0000805,5.56e-26,2;CL:0002425,5.56e-26,2;CL:0000084,1.02e-18,25;CL:0000827,1.02e-18,25;CL:0000838,1.73e-09,52;CL:0000542,2.52e-09,53;CL:0000051,2.52e-09,53 | |||
|ontology_enrichment_development_v019=CL:0002425;4.90e-26;2!CL:0000051;5.06e-07;53 | |||
|ontology_enrichment_disease=DOID:2531!1.19e-17!51;DOID:0060083!1.19e-17!51;DOID:1240!3.12e-16!39;DOID:0060058!6.94e-11!10 | |||
|ontology_enrichment_disease_v019=DOID:1240;8.92e-15;39!DOID:2531;3.64e-13;51!DOID:0060083;3.64e-13;51 | |||
|ontology_enrichment_disease_v019_2=DOID:1240,4.38e-21,39;DOID:2531,2.36e-16,51;DOID:0060083,2.36e-16,51 | |||
|ontology_enrichment_uberon=UBERON:0002370!1.26e-25!4;UBERON:0005058!1.26e-25!4;UBERON:0009113!1.26e-25!4;UBERON:0003295!1.26e-25!4;UBERON:0005562!1.26e-25!4;UBERON:0003351!1.85e-17!6;UBERON:0004177!4.07e-15!7;UBERON:0000974!6.94e-11!10;UBERON:0003408!6.94e-11!10;UBERON:0001042!6.94e-11!10;UBERON:0009145!6.94e-11!10;UBERON:0006562!5.54e-10!11;UBERON:0009722!5.54e-10!11;UBERON:0007690!5.54e-10!11;UBERON:0008814!1.44e-07!15 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002370,1.00e-13,4;UBERON:0005058,1.00e-13,4;UBERON:0009113,1.00e-13,4;UBERON:0003295,1.00e-13,4;UBERON:0005562,1.00e-13,4;UBERON:0003351,1.32e-09,6;UBERON:0004177,2.03e-08,7;UBERON:0005057,2.03e-08,7 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.32389366601898,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.02629888782524,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.47003968731907,0,0,1.1241165257259,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.67464122265948,0,0,0,0,0,0,0,0.16480387422676,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.41753560563109,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0620747142958579,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p15@PTPN3 | |||
}} |
Revision as of 02:41, 23 January 2014
Short description: | p15@PTPN3 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_15_at_PTPN3_5end |
Coexpression cluster: | C99_hairy_mycosis_submaxillary_salivary_cord_kidney_parotid |
Association with transcript: | -70bp_to_CR749204_5end |
EntrezGene: | PTPN3 |
HGNC: | 9655 |
UniProt: | Q68E08 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
innate effector T cell | 2.42e-50 | 1 |
immature NK T cell | 2.42e-50 | 1 |
effector T cell | 2.42e-50 | 1 |
mature NK T cell | 2.42e-50 | 1 |
immature NK T cell stage IV | 2.42e-50 | 1 |
immature NK T cell stage I | 2.42e-50 | 1 |
immature NK T cell stage II | 2.42e-50 | 1 |
immature NK T cell stage III | 2.42e-50 | 1 |
thymocyte | 5.56e-26 | 2 |
double negative thymocyte | 5.56e-26 | 2 |
double-positive, alpha-beta thymocyte | 5.56e-26 | 2 |
DN4 thymocyte | 5.56e-26 | 2 |
DN1 thymic pro-T cell | 5.56e-26 | 2 |
DN2 thymocyte | 5.56e-26 | 2 |
DN3 thymocyte | 5.56e-26 | 2 |
immature single positive thymocyte | 5.56e-26 | 2 |
early T lineage precursor | 5.56e-26 | 2 |
T cell | 1.02e-18 | 25 |
pro-T cell | 1.02e-18 | 25 |
lymphoid lineage restricted progenitor cell | 1.73e-09 | 52 |
lymphocyte | 2.52e-09 | 53 |
common lymphoid progenitor | 2.52e-09 | 53 |
Ontology term | p-value | n |
---|---|---|
thymus | 1.00e-13 | 4 |
hemolymphoid system gland | 1.00e-13 | 4 |
thymic region | 1.00e-13 | 4 |
pharyngeal gland | 1.00e-13 | 4 |
thymus primordium | 1.00e-13 | 4 |
pharyngeal epithelium | 1.32e-09 | 6 |
hemopoietic organ | 2.03e-08 | 7 |
immune organ | 2.03e-08 | 7 |
Ontology term | p-value | n |
---|---|---|
leukemia | 4.38e-21 | 39 |
hematologic cancer | 2.36e-16 | 51 |
immune system cancer | 2.36e-16 | 51 |